# Safety and Efficacy of the CryoCor™ Cardiac Cryoablation System for the Treatment of Atrial Flutter

> **NCT00113178** · PHASE3 · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 160 (—)

## Conditions studied

- Atrial Flutter

## Interventions

- **DEVICE:** Catheter-based cardiac cryoablation

## Key facts

- **NCT ID:** NCT00113178
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** —
- **Final completion:** 2005-06
- **Target enrollment:** 160 (—)
- **Last updated:** 2011-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00113178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00113178, "Safety and Efficacy of the CryoCor™ Cardiac Cryoablation System for the Treatment of Atrial Flutter". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00113178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*